According to statistics from the China Investment Group, in 2010, there were a total of 103 investment cases in the medical and health industry, with a total investment of 1.858 billion U.S. dollars. Investors’ enthusiasm for the healthcare industry is no less than that of the IT industry. Due to its practicality, the pharmaceutical industry is inherently resistant to the cyclical nature and is attracting more and more investors to participate in it, and is known as the "forever sunrise industry."
Recently, the industry leaders, industry leaders, and the list of top ten growth companies announced at the Summit of the New Leaders Forum Medical Industry will be the most economic models derived from the entire industrial chain of health, medical care, healthcare, medicine, and health. The wealth of investment value points to mutual confirmation.
According to the organizers of the Summit, the new leader was sponsored by the Chamber of Commerce of the National Federation of Industry and Commerce, and jointly with CCTV's “Entrepreneurship Angel†column, 29 representative companies on the list came from different segments. However, it is basically consistent with the current major investment areas, mainly in the direction of pharmaceutical manufacturing, medical services and medical and health.
Among them, in the field of pharmaceutical manufacturing, Tasly, Modified Pharmaceuticals, Yunnan Baiyao, and Kechuang Holdings, which have led the industry in this list, have all grown up to become representative brands of ethnic medicine. These companies have also maintained high-speed continuous growth. For example, Kechuang’s sales have exceeded 19 billion, and the compound annual growth rate of three-year sales is still as high as 427%. The revised pharmaceutical industry, which was once China’s top 100 growth company, still maintains. 125% growth. Revising Pharmaceutical Group Chairman Xiu Yugui said in a speech at the summit that on the one hand, Chinese medicine has a long history and is conducive to R&D. On the other hand, traditional Chinese medicine is increasingly recognized by the international community. Chinese pharmaceutical companies can make use of the innate advantages of Chinese medicine culture in China and strengthen the development and research of Chinese medicine so that the export of Chinese medicine can go in the direction of more high-end products.
It is worth mentioning that medical devices are the most favored in the medical and health industry. For instance, Yuyue Medical, the leading company in this industry, has established close cooperation relations with universities and research institutes and related universities and research institutes, increased investment in technology research and development, independent research and development, and enhanced independent innovation capabilities to enhance competitiveness, and become a capital market after listing. darling.
In addition, Shandong Global Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the US-based NASDAQ-listed Global Medicine Holdings Group, has also become a leader in the healthcare industry. The company integrates medicines wholesale and marketing, and its core business has covered many regions in Shandong Province and other regions in the country. At present, the company is committed to building a regional large-scale pharmaceutical distribution group consisting of a first-level logistics distribution center and a second-level distribution center, which will lay a good foundation for the future global pharmaceutical business distribution in China. (
Recently, the industry leaders, industry leaders, and the list of top ten growth companies announced at the Summit of the New Leaders Forum Medical Industry will be the most economic models derived from the entire industrial chain of health, medical care, healthcare, medicine, and health. The wealth of investment value points to mutual confirmation.
According to the organizers of the Summit, the new leader was sponsored by the Chamber of Commerce of the National Federation of Industry and Commerce, and jointly with CCTV's “Entrepreneurship Angel†column, 29 representative companies on the list came from different segments. However, it is basically consistent with the current major investment areas, mainly in the direction of pharmaceutical manufacturing, medical services and medical and health.
Among them, in the field of pharmaceutical manufacturing, Tasly, Modified Pharmaceuticals, Yunnan Baiyao, and Kechuang Holdings, which have led the industry in this list, have all grown up to become representative brands of ethnic medicine. These companies have also maintained high-speed continuous growth. For example, Kechuang’s sales have exceeded 19 billion, and the compound annual growth rate of three-year sales is still as high as 427%. The revised pharmaceutical industry, which was once China’s top 100 growth company, still maintains. 125% growth. Revising Pharmaceutical Group Chairman Xiu Yugui said in a speech at the summit that on the one hand, Chinese medicine has a long history and is conducive to R&D. On the other hand, traditional Chinese medicine is increasingly recognized by the international community. Chinese pharmaceutical companies can make use of the innate advantages of Chinese medicine culture in China and strengthen the development and research of Chinese medicine so that the export of Chinese medicine can go in the direction of more high-end products.
It is worth mentioning that medical devices are the most favored in the medical and health industry. For instance, Yuyue Medical, the leading company in this industry, has established close cooperation relations with universities and research institutes and related universities and research institutes, increased investment in technology research and development, independent research and development, and enhanced independent innovation capabilities to enhance competitiveness, and become a capital market after listing. darling.
In addition, Shandong Global Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the US-based NASDAQ-listed Global Medicine Holdings Group, has also become a leader in the healthcare industry. The company integrates medicines wholesale and marketing, and its core business has covered many regions in Shandong Province and other regions in the country. At present, the company is committed to building a regional large-scale pharmaceutical distribution group consisting of a first-level logistics distribution center and a second-level distribution center, which will lay a good foundation for the future global pharmaceutical business distribution in China. (
Guangdong Jia Mei Biological Technology Co.Ltd , https://www.jaymeimask.com